| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/23/2011 | US20110152243 Novel thienopyrrole compounds |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152234 Novel Compounds |
| 06/23/2011 | US20110152232 Sulfonamide compounds and uses thereof |
| 06/23/2011 | US20110152081 5-aryl isoxazolines for controlling invertebrate pests |
| 06/23/2011 | US20110150834 Crth2 modulators |
| 06/23/2011 | CA2784710A1 Oxadiazole derivative having endothelial lipase inhibitory activity |
| 06/23/2011 | CA2784528A1 Pyrrolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disorders as agonists of g-protein coupled receptor 43 (gpr43) |
| 06/23/2011 | CA2782601A1 Novel antiplatelet agent |
| 06/23/2011 | CA2782453A1 N-linked hydroxamic acid derivatives useful as antibacterial agents |
| 06/22/2011 | EP2336121A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives |
| 06/22/2011 | EP2335702A1 Product containing at least one phosphatase Cdc25 inhibitor combined with at least one other anticancer agent |
| 06/22/2011 | EP2335701A1 Heterocyclic aspartyl protease inhibitors |
| 06/22/2011 | EP2335700A1 Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| 06/22/2011 | EP2334666A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/22/2011 | EP2334662A1 Pyrine or pyrazine derivatives for treating hcv |
| 06/22/2011 | EP2334658A2 Ortho-aminoanilides for the treatment of cancer |
| 06/22/2011 | EP2334657A1 Piperazine d3 and 5-ht2a receptor modulators |
| 06/22/2011 | EP2334646A2 Substituted benzamides as cannabinoid receptor ligands |
| 06/22/2011 | EP2334637A1 Novel potassium channel blockers |
| 06/22/2011 | EP2334183A1 Sulfonamide derivative metabotropic glutamate r4 ligands |
| 06/22/2011 | EP1912979B1 Phenyl-{3-(3-(1h-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 06/22/2011 | EP1748985B1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 06/22/2011 | EP1546162B1 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 06/22/2011 | CN1898244B Triazole derivatives as vasopressin antagonists |
| 06/22/2011 | CN1845734B Benzimidazole derivatives and their use as protein kinases inhibitors |
| 06/22/2011 | CN102105468A Heterocyclic urea derivatives and methods of use thereof |
| 06/22/2011 | CN102105467A Tricyclic alkylaminomethyloxazolidinone derivatives |
| 06/22/2011 | CN102105466A Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators |
| 06/22/2011 | CN102105454A Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 06/22/2011 | CN102105448A Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states |
| 06/22/2011 | CN102101852A Coumarin derivates, preparation method thereof and application thereof in white-light organic electroluminescent device |
| 06/22/2011 | CN101633645B N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/22/2011 | CN101277698B Quinoline derivatives as antibacterial agents |
| 06/22/2011 | CN101175747B Substituted N-arylpyrrolidines as selective androgen receptor modulators |
| 06/22/2011 | CN101175736B Compound, composition, phase difference plate, elliptically polarizing plate and liquid crystal display device |
| 06/22/2011 | CN101115742B Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 06/21/2011 | US7964727 N-({1-[(cis-1,4-dihydroxycyclohexyl)methyl]piperidin-4-yl}methyl)-1-isopropyl-5-methyl-2-oxo-1, 2-dihydroquinoline-3-carboxamide ethanedioate; gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome |
| 06/21/2011 | US7964724 Chiral cis-imidazolines |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964628 Fibrinogen receptor antagonists and their use |
| 06/21/2011 | US7964624 Inhibitors of serine proteases |
| 06/21/2011 | US7964622 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 06/21/2011 | US7964597 Piperazinyl-sulfonamide derivatives useful in the treatment of GPR38 receptor mediated diseases |
| 06/21/2011 | US7964596 Therapeutic compounds |
| 06/21/2011 | US7964593 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 06/21/2011 | US7964531 3-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same |
| 06/21/2011 | CA2641379C Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 06/21/2011 | CA2577144C Alkynyl compounds as non-nucleoside reverse transcriptase inhibitors |
| 06/21/2011 | CA2516270C Oxadiazoline and thiadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/16/2011 | WO2011072241A1 4 -oxo- ih -quinoline- 3 - carboxamides as modulators of atp -binding cassette transporters |
| 06/16/2011 | WO2011071255A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/16/2011 | WO2011071136A1 Therapeutic agent for fibromyalgia |
| 06/16/2011 | WO2011071135A1 Oxazine derivative |
| 06/16/2011 | WO2011071095A1 Benzamide compound |
| 06/16/2011 | WO2011070179A1 Process for the preparation of propionic acid derivatives |
| 06/16/2011 | WO2011070039A1 Spiro indole - cyclopropane indolinones useful as ampk modulators |
| 06/16/2011 | WO2011070029A1 Amino oxazine derivatives |
| 06/16/2011 | WO2011069952A1 Novel cationic 4-aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof |
| 06/16/2011 | WO2011069934A1 2-amino-5, 5-difluoro-5, 6-dihydro-4h-oxazines as bace 1 and/or bace 2 inhibitors |
| 06/16/2011 | WO2011069898A1 Novel cationic aminopyridines, dye composition comprising a cationic aminopyridine, processes therefor and uses thereof |
| 06/16/2011 | WO2011069761A1 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof |
| 06/16/2011 | WO2011021726A3 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation |
| 06/16/2011 | US20110144334 Isoxazoline-substituted benzamide compound and pesticide |
| 06/16/2011 | US20110144333 4,5-dihydro-oxazol-2yl derivatives |
| 06/16/2011 | US20110144330 2,4-Pyrimidinediamine Compounds and their Uses |
| 06/16/2011 | US20110144326 Method for manufacturing stereoselective preparation of 4-BMA using a chiral auxiliary and chiral auxiliary |
| 06/16/2011 | US20110144169 Inhibitors of cellular necrosis |
| 06/16/2011 | US20110144164 Pyridone derivatives as NK3 antagonists |
| 06/16/2011 | US20110144153 Amide compound |
| 06/16/2011 | US20110144128 Heterocyclic Carboxamide Compounds as Steroid Nuclear Receptors Ligands |
| 06/16/2011 | US20110144119 Oxazole derivatives useful as inhibitors of faah |
| 06/16/2011 | US20110144112 Apoptosis promoters |
| 06/16/2011 | US20110144110 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/16/2011 | US20110144109 Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof |
| 06/16/2011 | US20110144108 Substituted piperidine compounds and methods of their use |
| 06/16/2011 | US20110144107 Compounds and compositions useful for the treatment of malaria |
| 06/16/2011 | US20110144106 Novel cyclopropane indolinone derivatives |
| 06/16/2011 | US20110144103 Pyrrole compounds that modulate hsp90 activity |
| 06/16/2011 | US20110144099 Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 06/16/2011 | US20110144098 Amino oxazine derivatives |
| 06/16/2011 | US20110144097 2-amino-5,5-difluoro-5,6-dihydro-4h-[1,3]oxazin-4-yl)-phenyl]-amides |
| 06/16/2011 | US20110144096 Treating various disorders using trkb agonists |
| 06/16/2011 | US20110144090 Compounds and methods of use thereof |
| 06/16/2011 | US20110144081 Pyrrolidine derivatives |
| 06/16/2011 | US20110144080 Pyrazole derivatives as protein kinase modulators |
| 06/16/2011 | US20110144075 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 06/16/2011 | US20110144070 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 06/16/2011 | US20110144068 3,4-diarylpyrazoles as protein kinase inhibitors |
| 06/16/2011 | US20110144067 N-Acyloxysulfonamide and N-Hydroxy-N-Acylsulfonamide Derivatives |
| 06/16/2011 | US20110144060 Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods |
| 06/16/2011 | US20110144056 Pyrazole derivatives useful as inhibitors of faah |
| 06/16/2011 | US20110143939 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use |
| 06/16/2011 | US20110143141 Photochromic compounds and compositions |
| 06/16/2011 | US20110142856 Compound containing basic group and use thereof |
| 06/16/2011 | US20110142798 Hepatitis c virus inhibitors |
| 06/16/2011 | US20110140056 Indeno-fused ring compounds |
| 06/16/2011 | US20110139654 Oxadiazole derivatives for the treatment of diabetes |